264 related articles for article (PubMed ID: 32006792)
1. Antiepileptic drug effects on subjective and objective cognition.
Quon RJ; Mazanec MT; Schmidt SS; Andrew AS; Roth RM; MacKenzie TA; Sajatovic M; Spruill T; Jobst BC
Epilepsy Behav; 2020 Mar; 104(Pt A):106906. PubMed ID: 32006792
[TBL] [Abstract][Full Text] [Related]
2. Evaluating subjective cognitive impairment in the adult epilepsy clinic: Effects of depression, number of antiepileptic medications, and seizure frequency.
Feldman L; Lapin B; Busch RM; Bautista JF
Epilepsy Behav; 2018 Apr; 81():18-24. PubMed ID: 29455082
[TBL] [Abstract][Full Text] [Related]
3. Changes in cognition after introduction or withdrawal of zonisamide versus topiramate in epilepsy patients: A retrospective study using Bayes statistics.
Meschede C; Witt JA; Brömling S; Moskau-Hartmann S; Rademacher M; Surges R; von Wrede R; Helmstaedter C
Epilepsia; 2020 Jul; 61(7):1481-1490. PubMed ID: 32557579
[TBL] [Abstract][Full Text] [Related]
4. Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation.
Wilby J; Kainth A; Hawkins N; Epstein D; McIntosh H; McDaid C; Mason A; Golder S; O'Meara S; Sculpher M; Drummond M; Forbes C
Health Technol Assess; 2005 Apr; 9(15):1-157, iii-iv. PubMed ID: 15842952
[TBL] [Abstract][Full Text] [Related]
5. EpiTrack: tracking cognitive side effects of medication on attention and executive functions in patients with epilepsy.
Lutz MT; Helmstaedter C
Epilepsy Behav; 2005 Dec; 7(4):708-14. PubMed ID: 16266826
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and cognitive side effects of tiagabine and topiramate in patients with epilepsy.
Fritz N; Glogau S; Hoffmann J; Rademacher M; Elger CE; Helmstaedter C
Epilepsy Behav; 2005 May; 6(3):373-81. PubMed ID: 15820346
[TBL] [Abstract][Full Text] [Related]
7. Cognitive profile of topiramate as compared with lamotrigine in epilepsy patients on antiepileptic drug polytherapy: relationships to blood serum levels and comedication.
Kockelmann E; Elger CE; Helmstaedter C
Epilepsy Behav; 2004 Oct; 5(5):716-21. PubMed ID: 15380124
[TBL] [Abstract][Full Text] [Related]
8. Cognition in school-aged children with "active" epilepsy: A population-based study.
Reilly C; Atkinson P; Das KB; Chin RF; Aylett SE; Burch V; Gillberg C; Scott RC; Neville BG
J Clin Exp Neuropsychol; 2015; 37(4):429-38. PubMed ID: 25921696
[TBL] [Abstract][Full Text] [Related]
9. Adverse effects & drug load of antiepileptic drugs in patients with epilepsy: Monotherapy versus polytherapy.
Joshi R; Tripathi M; Gupta P; Gulati S; Gupta YK
Indian J Med Res; 2017 Mar; 145(3):317-326. PubMed ID: 28749393
[TBL] [Abstract][Full Text] [Related]
10. Effect of antiepileptic drugs on cognitive function in individuals with epilepsy: a comparative review of newer versus older agents.
Brunbech L; Sabers A
Drugs; 2002; 62(4):593-604. PubMed ID: 11893228
[TBL] [Abstract][Full Text] [Related]
11. Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data.
Nevitt SJ; Sudell M; Cividini S; Marson AG; Tudur Smith C
Cochrane Database Syst Rev; 2022 Apr; 4(4):CD011412. PubMed ID: 35363878
[TBL] [Abstract][Full Text] [Related]
12. The longer-term cognitive effects of adjunctive antiepileptic treatment with lacosamide in comparison with lamotrigine and topiramate in a naturalistic outpatient setting.
Helmstaedter C; Witt JA
Epilepsy Behav; 2013 Feb; 26(2):182-7. PubMed ID: 23318473
[TBL] [Abstract][Full Text] [Related]
13. Quality of life and its association with comorbidities and adverse events from antiepileptic medications: Online survey of patients with epilepsy in Australia.
Welton JM; Walker C; Riney K; Ng A; Todd L; D'Souza WJ
Epilepsy Behav; 2020 Mar; 104(Pt A):106856. PubMed ID: 31954268
[TBL] [Abstract][Full Text] [Related]
14. Psychiatric and behavioral side effects of antiepileptic drugs in adults with epilepsy.
Chen B; Choi H; Hirsch LJ; Katz A; Legge A; Buchsbaum R; Detyniecki K
Epilepsy Behav; 2017 Nov; 76():24-31. PubMed ID: 28931473
[TBL] [Abstract][Full Text] [Related]
15. Assessment of psychiatric and behavioral adverse effects of antiepileptic drugs monotherapy: Could they have a neuroendocrine correlation in persons with epilepsy?
Sarangi SC; Kaur N; Tripathi M
Epilepsy Behav; 2019 Nov; 100(Pt A):106439. PubMed ID: 31574428
[TBL] [Abstract][Full Text] [Related]
16. Evolving antiepileptic drug treatment in juvenile myoclonic epilepsy.
Prasad A; Kuzniecky RI; Knowlton RC; Welty TE; Martin RC; Mendez M; Faught RE
Arch Neurol; 2003 Aug; 60(8):1100-5. PubMed ID: 12925366
[TBL] [Abstract][Full Text] [Related]
17. Is the computerized assessment of psychomotor speed more sensitive to cognitive effects of antiepileptic pharmacotherapy than tests with a focus on higher-order cognitive processing? Implications for the choice of sensitive test parameters.
Helmstaedter C; Durch P; Hoppe C; Witt JA
Eur Neuropsychopharmacol; 2019 Nov; 29(11):1273-1281. PubMed ID: 31606304
[TBL] [Abstract][Full Text] [Related]
18. Complaints associated with the use of antiepileptic drugs: results from a community-based study.
Carpay JA; Aldenkamp AP; van Donselaar CA
Seizure; 2005 Apr; 14(3):198-206. PubMed ID: 15797355
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of adverse drug reaction profile of antiepileptic drugs in persons with epilepsy: A cross-sectional study.
Kumar S; Sarangi SC; Tripathi M; Gupta YK
Epilepsy Behav; 2020 Apr; 105():106947. PubMed ID: 32109858
[TBL] [Abstract][Full Text] [Related]
20. Evaluating the longer-term cognitive effects of adjunctive perampanel compared to lacosamide in a naturalistic outpatient setting.
Meschede C; Witt JA; Rademacher M; von Wrede RD; Elger CE; Helmstaedter C
Seizure; 2018 May; 58():141-146. PubMed ID: 29704679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
